Marcin Hołota

Dr. Marcin Hołota

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Sylwia MichlewskaSylwia Michlewska
Sylwia Michlewska
MMMarek Maly
Marek Maly
DWDagmara Wojkowska
Dagmara Wojkowska
KKKamil Karolczak
Kamil Karolczak
ESElżbieta Skiba
Elżbieta Skiba
MIMaksim Ionov
Maksim Ionov

Verified
Journal Article
Open access
PDF file
MHMarcin Hołota
Marcin Hołota
MPMalgorzata M. Posmyk
Malgorzata M. Posmyk
Cancer is a serious group of diseases that is a huge problem on a global scale and is the second most common cause of death. Commonly used therapies do not always lead to the complete elimination of diseased cells or tissues and are also burdened with side effects that reduce the quality of life of patients. Due to these difficulties, new therapeutic approaches are still being sought. In recent years, there has been a return to interest in natural methods of treating various diseases, among which phytochemicals are particularly interesting. This article reviews plant extracts with anticancer properties with different mechanisms of action (proapoptotic, antiproliferative, antiangiogenic, immunomodulatory). In addition, plant extracts that reduce the side effects of chemotherapy and the limitations and prospects for the use of plant extracts in anticancer therapy are described. Our goal was to create an up-to-date information base that would encourage scientists to intensify research into supplementing targeted anticancer therapies with additional protective and preventive measures, in which natural mixtures of phytochemicals (plant extracts) are effective allies. At the same time, we encourage discussion on the limitations of their use in light of the orthodox principles of classical medicine and pharmacy (issues of safety, quality, drug purity, and dose precision), which are a priori correct but have not yet led to the elimination of cancer from the group of incurable diseases.

29 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
EOElżbieta Okła
Elżbieta Okła
MHMarcin Hołota
Marcin Hołota
Sylwia MichlewskaSylwia Michlewska
Sylwia Michlewska
SZSerafin Zawadzki
Serafin Zawadzki
KMKatarzyna Milowska
Katarzyna Milowska
Maksim IonovMaksim Ionov
Maksim Ionov
Background: The proportion of people suffering from neurodegenerative conditions, such as Alzheimer’s disease (AD), is increasing in the population year on year. Despite the constant effort of researchers, these conditions remain incurable and can only be managed by alleviation or delaying of symptoms. The lack of suitable treatment is caused by constricted access to the brain, limited by the brain-blood barrier. The aim of this work was to investigate two pegylated gold nanoparticles as potential carriers of therapeutic siRNA and their impact on the cellular functions of Human Brain Endothelial Cells. Methods and Results: Nanoparticles AuNP14a and AuNP14b complexed with siRNA were internalized by HBEC-5i cells and located in the cytoplasm. The genotoxicity assay proved that the nucleus was not affected and complexed nanoparticles did not cause DNA damage. The reactive oxygen species formation and mitochondrial membrane potential changes were measured and showed an adaptive response of cells after compound administration. Results obtained in a cytotoxicity assay conducted on astrocytes and pericytes, which are components of the blood–brain barrier, confirmed the biosafety of tested nanoparticles. Conclusions: In summary, it was shown that AuNP14a and AuNP14b are promising candidates as nanocarriers for therapeutic nucleic acids through biological barriers.

6 July 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Sylwia MichlewskaSylwia Michlewska
Sylwia Michlewska
MGMarika Grodzicka
Marika Grodzicka
MHMarcin Hołota
Marcin Hołota
ADAngela Dziedzic
Angela Dziedzic
Juris JansonsJuris Jansons
Juris Jansons
Maksim IonovMaksim Ionov
Maksim Ionov